Young Girl Left Unable To Talk Or Walk, Sleeps 23 Hours A Day After Getting Cervarix Vaccine For HPV
November 16, 2011
By Ethan A. Huff
“The HPV vaccine is a complete joke. It does nothing to help anyone. It causes far more harm than good. Big pharma is at it again.” –KTRN
Much of the attention concerning the dangers of getting vaccinated for human papillomavirus (HPV) and cervical cancer has been focused on Merck & Co.’s Gardasil. But a recent report in the UK’s Daily Mail explains that GlaxoSmithKline’s (GSK) Cervarix, a competing HPV vaccine, recently left an otherwise healthy girl in a “waking coma” where she is now unable to talk or walk, and sleeps 23 hours a day because of a complete lack of energy.
Lucy Hinks’ parents, Steve and Pauline, say their 13-year-old daughter used to be a straight-A student with an excellent school attendance record, and a penchant and adeptness for math. Everything changed, however, after Lucy received her third installment of the HPV vaccine Cervarix back in May, which has left her in a near-vegetative state and in need of 24-hour care and monitoring.
Beginning in September 2008, the UK Department of Health began a national vaccination program that included vaccinating young girls against HPV with Cervarix. All young girls in school are subjected to the shot unless their parents take the time to deliberately opt out of it — but just like in the US, most parents are pressured into accepting it for their daughters based on empty reassurances about its alleged safety.
“I was concerned about the potential side effects because Lucy had a severe reaction from the MMR vaccine. But I was reassured by the school nurse that side effects were extremely unlikely,” said Lucy’s mother Pauline to the Daily Mail. “We feel betrayed because, like most parents, we trust the health authorities with our children’s lives.”
October 28, 2011
By: Ethan A. Huff
In a shocking display of utter corruption and ignorance, a US Center for Disease Control and Prevention (CDC) advisory committee has officially declared that young boys and men between the ages of 11 and 21 should be vaccinated against human papillomavirus (HPV), the viral infection supposedly linked to causing cervical cancer in women.
Despite the fact that males do not even have a cervix, 12 of the 14 CDC committee members decided that vaccinating boys as young as nine against the virus is still a good idea. And in a separate vote, the majority of the committee members also decided that men as old as 26 should be vaccinated against HPV as well, which encompasses practically all young men.
The decision is founded in the CDC’s belief that Merck & Co.’s Gardasil and GlaxoSmithKline’s (GSK) Cervarix, the two vaccines approved for HPV, also help to prevent genital warts and various types of cancers in males. Such claims, though, have never actually been proven. The studies used as proof are skewed, and all of them were funded by the vaccine manufacturers.
There really is no solid medical proof that either Gardasil or Cervarix prevent HPV infections, cancer, or the transmission of HPV from men to women, as proponents of the vaccines claim.
“Though about 40 other countries have approved the vaccine (Gardasil) for males, there is still no medical proof Gardasil prevents penile cancer or other HPV-associated cancers in men,” says an Associated Press (AP) report from 2008. “There also is no evidence the vaccine prevents the spread of HPV from men to women.”
But the CDC advisory committee cannot let the facts get in the way of the pro-HPV vaccine agenda. A recent CNN report on the announcement even admits that the sudden push to vaccinate boys against HPV has little to do with actually stopping the spread of disease, and everything to do with getting as many people vaccinated as possible.
“One reason for the push now is that girls aren’t getting vaccinated in the numbers doctors had expected,” says the report. And the reason girls are not getting vaccinated is because HPV vaccines are linked to a host of very serious and deadly side effects, and have never been proven to be effective at preventing or treating anything.
October 4, 2011
USA Today. Your Life
A prolonged sore throat once was considered a cancer worry mainly for smokers and drinkers. Today there’s another risk: A sexually transmitted virus is fueling a rise in oral cancer.
The HPV virus is best known for causing cervical cancer. But it can cause cancer in the upper throat, too, and a new study says HPV-positive tumors now account for a majority of these cases of what is called oropharyngeal cancer.
If that trend continues, that type of oral cancer will become the nation’s main HPV-related cancer within the decade, surpassing cervical cancer, researchers from Ohio State University and the National Cancer Institute report Monday.
“There is an urgency to try to figure out how to prevent this,” says Dr. Amy Chen of the American Cancer Society and Emory University, who wasn’t part of the new research.
While women sometimes get oral cancer caused by the HPV, the risk is greatest and rising among men, researchers reported in the Journal of Clinical Oncology. No one knows why, but it begs the question of whether the vaccine given to girls and young women to protect against cervical cancer also might protect against oral HPV.
HPV vaccination is approved for boys to prevent genital warts and anal cancer, additional problems caused by human papillomavirus. But protection against oral HPV hasn’t been studied in either gender, says Dr. Maura Gillison, a head-and-neck cancer specialist at Ohio State and senior author of the new research. That’s important, because it’s possible to have HPV in one part of the body but not the other, she says.
A spokeswoman for Merck & Co., maker of the HPV vaccine Gardasil, said the company has no plans for an oral cancer study.
Monday’s research was funded by the NCI and Ohio State. Gillison has been a consultant to Merck.
There are nearly 10,000 new cases of oropharyngeal cancer a year, and overall incidence has risen by 28 percent since 1988 even as other types of head-and-neck cancer have been declining.
Tobacco and alcohol have long been the main causes of these tumors, which occur in the tonsils, base of the tongue and upper throat. But over the past few years, studies have shown HPV is playing a role in that rise, probably due to an increase in oral sex even as tobacco use was dropping.
The new study took a closer look, tracking HPV over time by directly testing tumor tissue from 271 patients that had been stored in cancer registries in Hawaii, Iowa and Los Angeles. The proportion that were HPV-positive rose from just 16 percent in the late 1980s to nearly 73 percent by the early 2000s.
Translate that to the overall population, and the researchers concluded that incidence rates of the HPV-positive tumors more than tripled while HPV-negative tumors dropped by half.
Oral cancer has always been a bigger threat to men than women. Gillison says women account for only about 1 in 4 cases, and their incidence is holding steady while men’s is rising. That raises questions about gender differences in sexual behavior or whether oral HPV infection is likely to linger longer in men.
While HPV is the most common sexually transmitted infection, studies show women’s bodies usually clear the virus from the cervix quickly; only an infection that persists for years is a cancer risk. It’s not known if oral HPV acts similarly or even is as common.
Nor is it clear if oral sex is the only way it’s transmitted, cautions Dr. Gregory Masters of the American Society for Clinical Oncology, an oncologist at Delaware’s Helen Graham Cancer Center.
Regardless, just over 11,000 cases of cervical cancer will be diagnosed this year, a number that has been dropping steadily thanks to better Pap smears. (It’s too soon to know what difference vaccination will make.) Gillison’s team calculated that annual cases of cervical cancer will drop to 7,700 by 2020 — compared with about 8,700 cases of HPV-positive oropharyngeal cancer by then, about 7,400 of them in men.
The cancer society’s Chen urged caution about those numbers, saying more data is needed. But she says two things are clear: First, patients with HPV-linked oral tumors have better survival odds than those with other types of this cancer, possibly because they tend to be younger. Studies are beginning to test if they can scale back today’s treatment and thus suffer fewer long-term side effects such as problems with speech and swallowing.
And “just because you’re not a smoker or drinker doesn’t mean you can’t get throat cancer,” Chen says — so get checked for symptoms like a throat that’s sore for longer than two weeks.
September 14th, 2011
By: Catalina Camia
GOP presidential hopeful Michele Bachmann is slamming rival Rick Perry’s executive order requiring Texas girls to get a vaccine against cervical cancer in a fundraising pitch for “emergency” funds.
Appearing this morning on NBC’s Today show, Bachmann repeated her line of attack from last night’s GOP debate and criticized Perry for “crony capitalism.” He signed an executive order in 2007 requiring sixth-grade girls to be inoculated for HPV, the virus that is the leading cause of cervical cancer.
“To have innocent little 12-year old girls be forced to have a government injection through an executive order is just flat out wrong,” Bachmann says in her e-mail requesting donations, titled “I’m Offended.”
Bachmann suggested at the debate, in her fundraising pitch and on TV today that Perry’s order was motivated by his ties to a former aide who works for Merck, the pharmaceutical giant that manufactures the vaccine.
Perry said at the debate that he was wrong not to consult the Texas Legislature on the issue, but he defended his executive order as something necessary to save lives. He said he was “offended” by Bachmann’s suggestion that his order was motivated by a campaign donation from Merck.
Bachmann, a Minnesota congresswoman with three biological daughters, is asking for donations of $25 or more in the fundraising pitch, saying she needs it to defeat President Obama.
Her attack on Perry over the HPV vaccination was endorsed by Sarah Palin, who told Fox News on Monday night that it’s tough to go against someone in your own political party.
“You have to go up against the big guns, and they will try to destroy you when you call them out on the mistakes they have made,” Palin said.
July 6th, 2011
Gov. Rick Perry ordered Friday that schoolgirls in Texas must be vaccinated against the sexually transmitted virus that causes cervical cancer, making Texas the first state to require the shots.
The girls will have to get Merck & Co.’s new vaccine against strains of the human papillomavirus, or HPV, that are responsible for most cases of cervical cancer.
Merck is bankrolling efforts to pass laws in state legislatures across the country mandating it Gardasil vaccine for girls as young as 11 or 12. It doubled its lobbying budget in Texas and has funneled money through Women in Government, an advocacy group made up of female state legislators around the country.
Details of the order were not immediately available, but the governor’s office confirmed to The Associated Press that he was signing the order and he would comment Friday afternoon.
Perry has several ties to Merck and Women in Government. One of the drug company’s three lobbyists in Texas is Mike Toomey, his former chief of staff. His current chief of staff’s mother-in-law, Texas Republican state Rep. Dianne White Delisi, is a state director for Women in Government.
Toomey was expected to be able to woo conservative legislators concerned about the requirement stepping on parent’s rights and about signaling tacit approval of sexual activity to young girls. Delisi, as head of the House public health committee, which likely would have considered legislation filed by a Democratic member, also would have helped ease conservative opposition.
Perry also received $6,000 from Merck’s political action committee during his re-election campaign.
It wasn’t immediately clear how long the order would last and whether the legislation was still necessary. However it could have been difficult to muster support from lawmakers who champion abstinence education and parents’ rights.
Perry, a conservative Christian who opposes abortion rights and stem- cell research using embryonic cells, counts on the religious right for his political base.
But he has said the cervical cancer vaccine is no different than the one that protects children against polio.
“If there are diseases in our society that are going to cost us large amounts of money, it just makes good economic sense, not to mention the health and well being of these individuals to have those vaccines available,” he said.
Texas allows parents to opt out of inoculations by filing an affidavit stating that he or she objected to the vaccine for religious or philosophical reasons.
Even with such provisions, however, conservative groups say mandates take away parents’ rights to be the primary medical decision maker for their children.
The federal government approved Gardasil in June, and a government advisory panel has recommended that all girls get the shots at 11 and 12, before they are likely to be sexually active.
The New Jersey-based drug company could generate billions in sales if Gardasil _ at $360 for the three-shot regimen _ were made mandatory across the country. Most insurance companies now cover the vaccine, which has been shown to have no serious side effects.
Merck spokeswoman Janet Skidmore would not say how much the company is spending on lobbyists or how much it has donated to Women in Government. Susan Crosby, the group’s president, also declined to specify how much the drug company gave.
A top official from Merck’s vaccine division sits on Women in Government’s business council, and many of the bills around the country have been introduced by members of Women in Government.
March 2nd, 2011
The Huffington Post
By: Dr. Jon LaPook
A study out yesterday in The Lancet by Moffitt Cancer Center researcher Anna Giuliano, Ph.D., and her colleagues finds that 50 percent of men ages 18 to 70 in Brazil, Mexico, and the U.S. have genital infection with human papillomavirus, or HPV. HPV is the virus that causes cervical cancer in women. It also causes warts and cancer of the genitals and anus in both men and women. Over the past several years, researchers have realized that the virus can also cause cancer of the head and neck.
Aimee R. Kreimer, Ph.D., of the National Cancer Institute, estimates that about 65 percent of the approximately 8,000 cancers of the oropharynx (tonsils and base of the tongue) seen in the U.S. in 2010 were from HPV infection; 80 percent of these are in men. The rates for HPV-associated cancers like these are increasing; for sites like the mouth and larynx that are associated with tobacco and alcohol use, the rates are decreasing (though still too high since too many people still smoke and abuse alcohol).
An infection rate of 50 percent for a virus that can cause cancer sounds scary. But knowing a few more facts about HPV helps put the risk in perspective. About 90 percent of men and women infected with HPV virus get rid of it on their own within about two years. There are many different strains of HPV — some that cause cancer and some that don’t. Only about 6 percent of men have genital infection with HPV 16 — the strain linked to more than 90 percent of cancers of the head and neck. And only about 0.6 percent of men have HPV 16 in specimens taken from their mouths; what percentage of those men go on to develop head and neck cancer is unknown.
Right now, there are many more questions than answers. How exactly does HPV get from the genitals to the mouth? Oral sex is one obvious answer but the virus may also be spread by the fingers, kissing, or some other unsuspected route. Why does the infection persist in 10 percent of people?
What’s urgently needed is some way of detecting the virus early — the oral equivalent of a Pap smear. Researchers are trying to develop such a test at centers like Johns Hopkins, where earlier this month I interviewed a 64-year-old man whose HPV-linked tongue cancer was picked up only incidentally because he happened to go to an ear, nose, and throat doctor to get ear wax removed. There’s got to be a better way of picking up asymptomatic HPV infection of the head and neck – before it progresses to cancer.
Finally, today’s study is sure to provoke discussion about whether an HPV vaccine like Gardasil should be routinely recommended by public health officials for males as it is for females. The vaccine covers four strains of HPV, including strain 16, the one most commonly linked to head and neck cancer. Right now, the CDC supports “permissive use” of the vaccine in males 9-26 but stops short of actually recommending its use.
December 21st, 2010
By: Paul Fassa
Recently in Florida, two teens from the same family came down with serious vaccine injuries from Gardasil vaccinations. That`s not unusual. Lots of young ladies have been injured from HPV vaccinations. But these teen siblings were not both female. The older brother had received the shot and was stricken also.
Several states were considering making HPV vaccinations mandatory for school children before they`re allowed to attend. Not only are these vaccinations proving to be dangerous with horrendous side effects, but they are also unnecessary. The disease it supposedly shields is rare, contagious only through sex, and usually heals with little or no treatment.
What HPV Vaccines are About
The medical claim is that HPV, or human papilloma virus, can be transmitted through sex and cause cervical cancer. So of course, there must be a vaccine created to prevent this. At first it was for the young ladies aged from as early as nine to twenty-six.
So why are males getting this shot now? The current claim is males can also contract or spread the HPV virus through sex. Somehow an HPV wart that may occur on the genitals can become cancerous? This nonsense is believed wholly by the media and school administrators as well as gullible parents.
But here`s what Dr. Diane Harper, who helped develop Gardasil, said to attendees of the Fourth International Public Conference on Vaccination: “Gardasil is largely unnecessary, and it has never been fully tested on females under the age of 15 …[there`s] little need for the vaccine”.
Dr. Harper revealed that 70 percent of HPV infected recover within a year without treatment. Within two years, 90 percent recover. Of the remaining ten percent, few become cancerous. She further stated that cervical cancer is treatable and diminishing.
HPV is simply a medical term for genital warts. There are over 120 strains, and 99 percent of them are harmless.
Bury the Vaccine Damage; Blame the Victims
The two Florida teenagers had terrible side effects, typical of thousands who had received one or all three of the HPV vaccination series over the past few years. The younger girl had a grand mal seizure, a type of epileptic fit involving the whole body. First the authorities accused the girl of taking drugs. Because of her facial injuries from thrashing about during the seizure, they accused the father of beating her.
A few months later, the older son also had a grand mal seizure after his HPV vaccination. Although the mother had managed to discover the connection for the daughter`s reactions to HPV vaccinations, the doctors had a hard time believing the son even had the shot. They were convinced that HPV vaccinations were only for girls!
Both teenagers still have lingering problems after their initial seizures, even though they did not continue with the complete HPV vaccination series of three shots.
A Long List of Victims
The Florida incidents occurred after assurances that there were no dangers from the vaccinations. After all, what harm would aluminum adjuvants, polysorbate 80, which induces sterility, and sodium borate, used in roach poisons and known to cause seizures and death, cause when injected directly into the bloodstream?
By clicking a couple of the links in the sources section below, you`ll discover some of the reported incidents which include seizures, permanent early dementia, paralysis, and death from HPV vaccine injuries.
SaneVax lists almost 20,600 adverse events and 89 deaths from HPV vaccinations. These episodes are only what have been reported. There have to be more since many are unwilling or unable to make the connection of serious health problems from vaccinations.
August 26, 2010
By: Ethan A. Huff
Merck & Co., Inc., manufacturer of the human papillomavirus (HPV) vaccine Gardasil, continues to get away with pushing the dangerous drug on both young girls — and now boys — as a supposed prevention method for avoiding cervical cancer. But concerned mothers of daughters who have been seriously injured or killed by Gardasil have put together a website at http://truthaboutgardasil.org that tells the true story about this toxic vaccine.
The U.S. Food and Drug Administration (FDA) first approved Gardasil in the U.S. market back in 2006, and as of February 2009, more than 40 million doses of the vaccine have been administered worldwide. Though Merck touts Gardasil as being safe and effective in preventing cervical cancer, the vaccine is loaded with toxic chemicals that have injured and killed thousands of girls.
According to The Truth About Gardasil, young girls who receive one or all of the three-shot Gardasil vaccine schedule often suffer from extreme side effects, including seizures, strokes, autoimmune disorders, chronic fatigue, hair loss, headaches, heart pain, weak muscles, disrupted menstrual cycles, vision and hearing loss and even paralysis, just to name a few. Some girls have even died after receiving the shots.
Marian Greene, social activist and mother of a child injured by vaccines, created truthaboutgardasil.org to raise awareness about the dangers of Gardasil, and vaccines in general. By sharing stories and other news about the damage caused by the shot, Greene hopes that eventually the vaccine will be pulled from the market.
The group’s board of directors includes a mother whose daughter was also seriously injured by Gardasil, as well as another whose daughter died after getting the vaccine.
With Merck now recommending the vaccine for young boys — and conducting new campaigns to push the vaccine in developing nations around the world — it is imperative that the truth about Gardasil be spread far and wide.
December 30, 2009
By Ritu Bhatia
Women’s groups and doctors slammed advertisements issued by two pharmaceutical majors that claimed vaccination against (HPV) was the best way of preventing cervical cancer.
The objection from Sama Resource Centre for Women and Health and Saheli Women’s Resource Centre to Glaxo-SmithKline (GSK) India and Merck marketing HPV vaccines as a “protection against cervical cancer” comes a few days after the Central Drugs Standards Control Organisation (CDSCO) also took notice of the advertisements.
In a showcause notice issued to GSK India, the CDSCO cited objections raised by experts who said that the advertisements claiming that a vaccine can prevent cervical cancer were inaccurate and misleading. According to doctors, the drug majors appear to have oversimplified the complexity of cervical cancer and this could mislead consumers.
Researchers also point out that protection from HPV need not always translate into protection from cancer. “The vaccination doesn’t always protect women from cervical cancer because this virus isn’t the only cause of cervical cancer,” said Dr Sidharth Sahni, a surgical oncology consultant at Artemis Health Institute.
The available HPV vaccines protect against only two types of viruses associated with cervical cancer. “There are several types of HPVs associated with cervical cancer, and vaccines have not been proved to be effective against all of them,” said Bhudev Chandra Das, former director of the Institute of Cytology and Preventive Oncology and now a professor of biomedical research at Delhi University.
Ideally, the HPV vaccine should be administered to adolescent girls. Over the past year, paediatricians across the country have been urging parents of teenagers to administer them this vaccine.
But what many fail to mention is that this should only be given to those who have had no sexual exposure. “We first need to identify the target group for this vaccination,” Sahni added.
Vani Subramaniam of Saheli said the pharmaceutical companies were hiding information about the side effects of the vaccines. According to Anjali Shenoy of Sama, the health lobby should concentrate more on increasing awareness on screening the cancer rather than its vaccines.
November 20, 2009
By Lauren Cox and Dr. Joshua Hundert
Pap smears may no longer be called “annuals” if doctors follow new cervical cancer screening recommendations from the American College of Obstetricians and Gynecologists.
The group announced today that women should start getting cervical cancer screenings at age 21 instead of 18, and that women could wait longer between the screenings — regardless of when a woman starts having sex.
Women in their 20s with normal Pap smear results now should get screenings every two years instead of every year, and women in their 30s can wait three years between screenings, according to the new ACOG guidelines.
After a week of uproar over the controversial recommendations for less mammogram screenings for women, doctors say they will have to wait and see how the public reacts to the new pap smear guidelines.
“This is not a radical change in screening practices. This is something that’s been coming gradually since the 1980s,” said Dr. Alan G. Waxman, who helped write the new guidelines.
Some doctors hailed the decision as a way to reduce a host of problems caused by excessive screening; yet, a few others worried it might trigger more women to neglect annual checkups with gynecologists.
Waxman said the move toward fewer screenings will reduce unnecessary treatment in young women and protect them from future pregnancy complications.
On one hand, college-aged women have very high HPV infection rates. Dr. John Curtin, of The Cancer Institute at NYU Langone Medical Center in New York City said 70 percent of all college-aged sexually active people have contracted HPV. These high infection rates translate into a high number of abnormal pap smears.